HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Felice Pasini Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2019An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer.
1/2019Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial.
1/2019Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms.
10/2018Oral Metronomic Vinorelbine (OMV) in elderly or pretreated patients with advanced non small cell lung cancer: outcome and pharmacokinetics in the real world.
2/2016Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.
1/2006Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.
1/2005Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Felice Pasini Research Topics

Disease

13Neoplasms (Cancer)
01/2018 - 05/2002
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 01/2005
6Carcinoma (Carcinomatosis)
03/2005 - 05/2003
5Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2016
5Adenocarcinoma
01/2017 - 01/2003
4Breast Neoplasms (Breast Cancer)
10/2020 - 12/2011
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2013 - 10/2005
3Lung Neoplasms (Lung Cancer)
10/2018 - 06/2004
3Colorectal Neoplasms (Colorectal Cancer)
09/2011 - 09/2006
2Colonic Neoplasms (Colon Cancer)
01/2021 - 01/2018
2Disease Progression
02/2017 - 04/2010
2Stomach Neoplasms (Stomach Cancer)
10/2011 - 01/2003
2Neoplasm Metastasis (Metastasis)
04/2010 - 01/2005
2Lymphoma (Lymphomas)
08/2005 - 09/2004
2Carcinoid Tumor (Carcinoid)
03/2005 - 11/2003
2Lymphatic Metastasis
03/2005 - 11/2003
2Small Cell Carcinoma
11/2004 - 11/2003
1Kidney Neoplasms (Kidney Cancer)
10/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2017
1Lymphocytosis
02/2017
1Prostatic Neoplasms (Prostate Cancer)
10/2016
1Adenoma (Adenomas)
10/2016
1Esophageal Neoplasms (Esophageal Cancer)
03/2013
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2011
1Rectal Neoplasms (Rectal Cancer)
08/2009
1Glioma (Gliomas)
12/2008
1Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2005
1Sarcoma (Soft Tissue Sarcoma)
05/2004
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2002

Drug/Important Bio-Agent (IBA)

6fascinIBA
04/2007 - 05/2003
5Vinorelbine (Navelbine)FDA LinkGeneric
01/2019 - 02/2016
5Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 09/2006
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 09/2006
2Sunitinib (Sutent)FDA Link
10/2020 - 01/2016
2Leucovorin (Folinic Acid)FDA Link
01/2018 - 09/2006
2Cadherins (E-Cadherin)IBA
03/2005 - 11/2003
2Proteins (Proteins, Gene)FDA Link
01/2005 - 11/2003
1Biological ProductsIBA
01/2021
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
10/2020
14-hydroxy-N-desmethyltamoxifenIBA
10/2020
1TamoxifenFDA LinkGeneric
10/2020
1PlatinumIBA
01/2019
1Capecitabine (Xeloda)FDA Link
01/2018
1Estrogen ReceptorsIBA
01/2018
1Metalloproteases (Metalloproteinases)IBA
02/2017
1fluoromethylcholineIBA
10/2016
1Choline (Choline Chloride)IBA
10/2016
1pazopanibFDA Link
01/2016
1MicroRNAs (MicroRNA)IBA
01/2016
1Cell-Free Nucleic AcidsIBA
01/2015
1Cisplatin (Platino)FDA LinkGeneric
03/2013
1Docetaxel (Taxotere)FDA Link
03/2013
1Biomarkers (Surrogate Marker)IBA
12/2011
1Uridine Monophosphate (UMP)IBA
10/2011
1A 17 (A-17)IBA
04/2010
1Temozolomide (Temodar)FDA LinkGeneric
12/2008
1telomerase RNA (bTR)IBA
04/2007
1Irinotecan (Camptosar)FDA LinkGeneric
09/2006
1Messenger RNA (mRNA)IBA
01/2006
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2006
1AnthracyclinesIBA
08/2005
1beta CateninIBA
03/2005
1Reduced Folate Carrier ProteinIBA
09/2004
1Methotrexate (Mexate)FDA LinkGeneric
09/2004
1Cytarabine (Cytosar-U)FDA LinkGeneric
09/2004
1Cyclin EIBA
06/2004
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2004
1Codon (Codons)IBA
05/2004
1Monoclonal AntibodiesIBA
11/2003
1S100 Proteins (S 100 Protein)IBA
09/2003
1Mucin-1 (CA 15-3 Antigen)IBA
09/2003
1Ki-67 Antigen (Ki 67 Antigen)IBA
09/2003
1Carcinoembryonic AntigenIBA
09/2003
1VimentinIBA
09/2003
1DesminIBA
09/2003
1Chromogranin AIBA
05/2003
1Hormones (Hormone)IBA
05/2003
1SynaptophysinIBA
05/2003

Therapy/Procedure

8Drug Therapy (Chemotherapy)
01/2019 - 05/2002
7Therapeutics
01/2021 - 05/2002
4Radiotherapy
03/2013 - 05/2002
3Neoadjuvant Therapy
03/2013 - 11/2004
3Chemoradiotherapy
12/2008 - 10/2005
2Nephrectomy
10/2020 - 11/2019
1Combination Drug Therapy (Combination Chemotherapy)
10/2011
1Laparotomy
01/2005
1Lymph Node Excision (Lymph Node Dissection)
01/2003
1Gastrectomy
01/2003
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
05/2002